تقرير
Impact of GLP-1 RAs Compared to Basal Insulin Start in Patients Living With Type 2 Diabetes and Chronic Kidney Disease
| العنوان: | Impact of GLP-1 RAs Compared to Basal Insulin Start in Patients Living With Type 2 Diabetes and Chronic Kidney Disease |
|---|---|
| المؤلفون: | Novo Nordisk Canada Inc. |
| المصدر: | Impact of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Compared to Basal Insulin Start on Metabolic Targets in Patients Living With Type 2 Diabetes and Chronic Kidney Disease (Impact GLP-1 CKD) |
| الوصول الحر: | https://clinicaltrials.gov/ct2/show/NCT06236672Test |
| قاعدة البيانات: | ClinicalTrials.gov |
| الوصف غير متاح. |